Engineering Self-Assembled Nanomedicines Composed of Clinically Approved Medicines for Enhanced Tumor Nanotherapy

The traditional nanocarriers are typically constructed to deliver anticancer agents for improving drug bioavailability and enhancing chemotherapeutic efficacy, but this strategy suffers from the critical issue of nanocarrier biosafety that hinders further clinical translation. In this work, a unique...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Quzi, Yu, Luodan, Chen, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534536/
https://www.ncbi.nlm.nih.gov/pubmed/37764528
http://dx.doi.org/10.3390/nano13182499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534536/
https://www.ncbi.nlm.nih.gov/pubmed/37764528
http://dx.doi.org/10.3390/nano13182499

Ejemplares similares